Impact of postoperative dexamethasone on survival, steroid dependency, and infections in newly diagnosed glioblastoma patients.
Akshitkumar M MistrySumeeth V JonathanMeredith A MonsourBret C MobleyStephen W ClarkPaul L MootsPublished in: Neuro-oncology practice (2021)
Lower survival, steroid dependency, and higher infection rate in glioblastoma patients associated with higher dexamethasone administration in the initial 3 postoperative weeks. Nearly half of the glioblastoma patients are lymphopenic preoperatively and up to 1 month postoperatively.